Global Biosimilar Supply, Demand and Key Producers, 2026-2032
The global Biosimilar market size is expected to reach $ million by 2032, rising at a market growth of %CAGR during the forecast period (2026-2032).
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original 'innovator' products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
Unlike with generic drugs of the more common small-molecule type, biologics generally exhibit high molecular complexity and may be quite sensitive to changes in manufacturing processes. Despite that heterogeneity, all biopharmaceuticals, including biosimilar, must maintain consistent quality and clinical performance throughout their lifecycle.
In this report is a biologic defined as proteins, peptides, hormones or antibody?s drugs production by bio-engineered technology, but does not include a vaccine.
China?s core biosimilar players include Qilu Pharmaceutical, Shanghai Henlius and 3SBIO etc. The top 3 companies only hold a share about 61%.
In terms of product, biosimilar monoclonal antibodies is the largest segment, with a share about 85%. And in terms of application, the largest application is cancer?with a share about 50%.
This report studies the global Biosimilar demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biosimilar that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biosimilar total market, 2021-2032, (USD Million)
Global Biosimilar total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Biosimilar total market, key domestic companies, and share, (USD Million)
Global Biosimilar revenue by player, revenue and market share 2021-2026, (USD Million)
Global Biosimilar total market by Type, CAGR, 2021-2032, (USD Million)
Global Biosimilar total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Biosimilar market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qilu Pharmaceutical, Bio-Thera, Zhejiang Hisun, Shanghai Henlius, Innovent Biologics, Jiangsu Hengrui, Gan&Lee, Tonghua Dongbao, United Laboratory, 3SBIO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Biosimilar Market, By Region:
1. How big is the global Biosimilar market?
2. What is the demand of the global Biosimilar market?
3. What is the year over year growth of the global Biosimilar market?
4. What is the total value of the global Biosimilar market?
5. Who are the Major Players in the global Biosimilar market?
6. What are the growth factors driving the market demand?
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original 'innovator' products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
Unlike with generic drugs of the more common small-molecule type, biologics generally exhibit high molecular complexity and may be quite sensitive to changes in manufacturing processes. Despite that heterogeneity, all biopharmaceuticals, including biosimilar, must maintain consistent quality and clinical performance throughout their lifecycle.
In this report is a biologic defined as proteins, peptides, hormones or antibody?s drugs production by bio-engineered technology, but does not include a vaccine.
China?s core biosimilar players include Qilu Pharmaceutical, Shanghai Henlius and 3SBIO etc. The top 3 companies only hold a share about 61%.
In terms of product, biosimilar monoclonal antibodies is the largest segment, with a share about 85%. And in terms of application, the largest application is cancer?with a share about 50%.
This report studies the global Biosimilar demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biosimilar that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biosimilar total market, 2021-2032, (USD Million)
Global Biosimilar total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Biosimilar total market, key domestic companies, and share, (USD Million)
Global Biosimilar revenue by player, revenue and market share 2021-2026, (USD Million)
Global Biosimilar total market by Type, CAGR, 2021-2032, (USD Million)
Global Biosimilar total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Biosimilar market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qilu Pharmaceutical, Bio-Thera, Zhejiang Hisun, Shanghai Henlius, Innovent Biologics, Jiangsu Hengrui, Gan&Lee, Tonghua Dongbao, United Laboratory, 3SBIO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Biosimilar Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Biosimilar Monoclonal Antibodies
- Biosimilar Insulin
- Others
- Cancer
- Immunological Diseases
- Diabetes
- Others
- Qilu Pharmaceutical
- Bio-Thera
- Zhejiang Hisun
- Shanghai Henlius
- Innovent Biologics
- Jiangsu Hengrui
- Gan&Lee
- Tonghua Dongbao
- United Laboratory
- 3SBIO
- Luye Pharma
1. How big is the global Biosimilar market?
2. What is the demand of the global Biosimilar market?
3. What is the year over year growth of the global Biosimilar market?
4. What is the total value of the global Biosimilar market?
5. Who are the Major Players in the global Biosimilar market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Biosimilar Introduction
1.2 World Biosimilar Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Biosimilar Total Market by Region (by Headquarter Location)
1.3.1 World Biosimilar Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Biosimilar Revenue (2021-2032)
1.3.3 China Based Company Biosimilar Revenue (2021-2032)
1.3.4 Europe Based Company Biosimilar Revenue (2021-2032)
1.3.5 Japan Based Company Biosimilar Revenue (2021-2032)
1.3.6 South Korea Based Company Biosimilar Revenue (2021-2032)
1.3.7 ASEAN Based Company Biosimilar Revenue (2021-2032)
1.3.8 India Based Company Biosimilar Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biosimilar Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Biosimilar Consumption Value (2021-2032)
2.2 World Biosimilar Consumption Value by Region
2.2.1 World Biosimilar Consumption Value by Region (2021-2026)
2.2.2 World Biosimilar Consumption Value Forecast by Region (2027-2032)
2.3 United States Biosimilar Consumption Value (2021-2032)
2.4 China Biosimilar Consumption Value (2021-2032)
2.5 Europe Biosimilar Consumption Value (2021-2032)
2.6 Japan Biosimilar Consumption Value (2021-2032)
2.7 South Korea Biosimilar Consumption Value (2021-2032)
2.8 ASEAN Biosimilar Consumption Value (2021-2032)
2.9 India Biosimilar Consumption Value (2021-2032)
3 WORLD BIOSIMILAR COMPANIES COMPETITIVE ANALYSIS
3.1 World Biosimilar Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biosimilar Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biosimilar in 2025
3.2.3 Global Concentration Ratios (CR8) for Biosimilar in 2025
3.3 Biosimilar Company Evaluation Quadrant
3.4 Biosimilar Market: Overall Company Footprint Analysis
3.4.1 Biosimilar Market: Region Footprint
3.4.2 Biosimilar Market: Company Product Type Footprint
3.4.3 Biosimilar Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biosimilar Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biosimilar Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Biosimilar Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Biosimilar Consumption Value Comparison
4.2.1 United States VS China: Biosimilar Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Biosimilar Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Biosimilar Companies and Market Share, 2021-2026
4.3.1 United States Based Biosimilar Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biosimilar Revenue, (2021-2026)
4.4 China Based Companies Biosimilar Revenue and Market Share, 2021-2026
4.4.1 China Based Biosimilar Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biosimilar Revenue, (2021-2026)
4.5 Rest of World Based Biosimilar Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Biosimilar Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Biosimilar Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Biosimilar Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Biosimilar Monoclonal Antibodies
5.2.2 Biosimilar Insulin
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Biosimilar Market Size by Type (2021-2026)
5.3.2 World Biosimilar Market Size by Type (2027-2032)
5.3.3 World Biosimilar Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biosimilar Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Immunological Diseases
6.2.3 Diabetes
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Biosimilar Market Size by Application (2021-2026)
6.3.2 World Biosimilar Market Size by Application (2027-2032)
6.3.3 World Biosimilar Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Qilu Pharmaceutical
7.1.1 Qilu Pharmaceutical Details
7.1.2 Qilu Pharmaceutical Major Business
7.1.3 Qilu Pharmaceutical Biosimilar Product and Services
7.1.4 Qilu Pharmaceutical Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Qilu Pharmaceutical Recent Developments/Updates
7.1.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
7.2 Bio-Thera
7.2.1 Bio-Thera Details
7.2.2 Bio-Thera Major Business
7.2.3 Bio-Thera Biosimilar Product and Services
7.2.4 Bio-Thera Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Bio-Thera Recent Developments/Updates
7.2.6 Bio-Thera Competitive Strengths & Weaknesses
7.3 Zhejiang Hisun
7.3.1 Zhejiang Hisun Details
7.3.2 Zhejiang Hisun Major Business
7.3.3 Zhejiang Hisun Biosimilar Product and Services
7.3.4 Zhejiang Hisun Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Zhejiang Hisun Recent Developments/Updates
7.3.6 Zhejiang Hisun Competitive Strengths & Weaknesses
7.4 Shanghai Henlius
7.4.1 Shanghai Henlius Details
7.4.2 Shanghai Henlius Major Business
7.4.3 Shanghai Henlius Biosimilar Product and Services
7.4.4 Shanghai Henlius Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Shanghai Henlius Recent Developments/Updates
7.4.6 Shanghai Henlius Competitive Strengths & Weaknesses
7.5 Innovent Biologics
7.5.1 Innovent Biologics Details
7.5.2 Innovent Biologics Major Business
7.5.3 Innovent Biologics Biosimilar Product and Services
7.5.4 Innovent Biologics Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Innovent Biologics Recent Developments/Updates
7.5.6 Innovent Biologics Competitive Strengths & Weaknesses
7.6 Jiangsu Hengrui
7.6.1 Jiangsu Hengrui Details
7.6.2 Jiangsu Hengrui Major Business
7.6.3 Jiangsu Hengrui Biosimilar Product and Services
7.6.4 Jiangsu Hengrui Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Jiangsu Hengrui Recent Developments/Updates
7.6.6 Jiangsu Hengrui Competitive Strengths & Weaknesses
7.7 Gan&Lee
7.7.1 Gan&Lee Details
7.7.2 Gan&Lee Major Business
7.7.3 Gan&Lee Biosimilar Product and Services
7.7.4 Gan&Lee Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Gan&Lee Recent Developments/Updates
7.7.6 Gan&Lee Competitive Strengths & Weaknesses
7.8 Tonghua Dongbao
7.8.1 Tonghua Dongbao Details
7.8.2 Tonghua Dongbao Major Business
7.8.3 Tonghua Dongbao Biosimilar Product and Services
7.8.4 Tonghua Dongbao Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Tonghua Dongbao Recent Developments/Updates
7.8.6 Tonghua Dongbao Competitive Strengths & Weaknesses
7.9 United Laboratory
7.9.1 United Laboratory Details
7.9.2 United Laboratory Major Business
7.9.3 United Laboratory Biosimilar Product and Services
7.9.4 United Laboratory Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 United Laboratory Recent Developments/Updates
7.9.6 United Laboratory Competitive Strengths & Weaknesses
7.10 3SBIO
7.10.1 3SBIO Details
7.10.2 3SBIO Major Business
7.10.3 3SBIO Biosimilar Product and Services
7.10.4 3SBIO Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 3SBIO Recent Developments/Updates
7.10.6 3SBIO Competitive Strengths & Weaknesses
7.11 Luye Pharma
7.11.1 Luye Pharma Details
7.11.2 Luye Pharma Major Business
7.11.3 Luye Pharma Biosimilar Product and Services
7.11.4 Luye Pharma Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Luye Pharma Recent Developments/Updates
7.11.6 Luye Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biosimilar Industry Chain
8.2 Biosimilar Upstream Analysis
8.3 Biosimilar Midstream Analysis
8.4 Biosimilar Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Biosimilar Introduction
1.2 World Biosimilar Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Biosimilar Total Market by Region (by Headquarter Location)
1.3.1 World Biosimilar Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Biosimilar Revenue (2021-2032)
1.3.3 China Based Company Biosimilar Revenue (2021-2032)
1.3.4 Europe Based Company Biosimilar Revenue (2021-2032)
1.3.5 Japan Based Company Biosimilar Revenue (2021-2032)
1.3.6 South Korea Based Company Biosimilar Revenue (2021-2032)
1.3.7 ASEAN Based Company Biosimilar Revenue (2021-2032)
1.3.8 India Based Company Biosimilar Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biosimilar Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Biosimilar Consumption Value (2021-2032)
2.2 World Biosimilar Consumption Value by Region
2.2.1 World Biosimilar Consumption Value by Region (2021-2026)
2.2.2 World Biosimilar Consumption Value Forecast by Region (2027-2032)
2.3 United States Biosimilar Consumption Value (2021-2032)
2.4 China Biosimilar Consumption Value (2021-2032)
2.5 Europe Biosimilar Consumption Value (2021-2032)
2.6 Japan Biosimilar Consumption Value (2021-2032)
2.7 South Korea Biosimilar Consumption Value (2021-2032)
2.8 ASEAN Biosimilar Consumption Value (2021-2032)
2.9 India Biosimilar Consumption Value (2021-2032)
3 WORLD BIOSIMILAR COMPANIES COMPETITIVE ANALYSIS
3.1 World Biosimilar Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biosimilar Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biosimilar in 2025
3.2.3 Global Concentration Ratios (CR8) for Biosimilar in 2025
3.3 Biosimilar Company Evaluation Quadrant
3.4 Biosimilar Market: Overall Company Footprint Analysis
3.4.1 Biosimilar Market: Region Footprint
3.4.2 Biosimilar Market: Company Product Type Footprint
3.4.3 Biosimilar Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biosimilar Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biosimilar Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Biosimilar Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Biosimilar Consumption Value Comparison
4.2.1 United States VS China: Biosimilar Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Biosimilar Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Biosimilar Companies and Market Share, 2021-2026
4.3.1 United States Based Biosimilar Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biosimilar Revenue, (2021-2026)
4.4 China Based Companies Biosimilar Revenue and Market Share, 2021-2026
4.4.1 China Based Biosimilar Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biosimilar Revenue, (2021-2026)
4.5 Rest of World Based Biosimilar Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Biosimilar Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Biosimilar Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Biosimilar Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Biosimilar Monoclonal Antibodies
5.2.2 Biosimilar Insulin
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Biosimilar Market Size by Type (2021-2026)
5.3.2 World Biosimilar Market Size by Type (2027-2032)
5.3.3 World Biosimilar Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biosimilar Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Immunological Diseases
6.2.3 Diabetes
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Biosimilar Market Size by Application (2021-2026)
6.3.2 World Biosimilar Market Size by Application (2027-2032)
6.3.3 World Biosimilar Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Qilu Pharmaceutical
7.1.1 Qilu Pharmaceutical Details
7.1.2 Qilu Pharmaceutical Major Business
7.1.3 Qilu Pharmaceutical Biosimilar Product and Services
7.1.4 Qilu Pharmaceutical Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Qilu Pharmaceutical Recent Developments/Updates
7.1.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
7.2 Bio-Thera
7.2.1 Bio-Thera Details
7.2.2 Bio-Thera Major Business
7.2.3 Bio-Thera Biosimilar Product and Services
7.2.4 Bio-Thera Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Bio-Thera Recent Developments/Updates
7.2.6 Bio-Thera Competitive Strengths & Weaknesses
7.3 Zhejiang Hisun
7.3.1 Zhejiang Hisun Details
7.3.2 Zhejiang Hisun Major Business
7.3.3 Zhejiang Hisun Biosimilar Product and Services
7.3.4 Zhejiang Hisun Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Zhejiang Hisun Recent Developments/Updates
7.3.6 Zhejiang Hisun Competitive Strengths & Weaknesses
7.4 Shanghai Henlius
7.4.1 Shanghai Henlius Details
7.4.2 Shanghai Henlius Major Business
7.4.3 Shanghai Henlius Biosimilar Product and Services
7.4.4 Shanghai Henlius Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Shanghai Henlius Recent Developments/Updates
7.4.6 Shanghai Henlius Competitive Strengths & Weaknesses
7.5 Innovent Biologics
7.5.1 Innovent Biologics Details
7.5.2 Innovent Biologics Major Business
7.5.3 Innovent Biologics Biosimilar Product and Services
7.5.4 Innovent Biologics Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Innovent Biologics Recent Developments/Updates
7.5.6 Innovent Biologics Competitive Strengths & Weaknesses
7.6 Jiangsu Hengrui
7.6.1 Jiangsu Hengrui Details
7.6.2 Jiangsu Hengrui Major Business
7.6.3 Jiangsu Hengrui Biosimilar Product and Services
7.6.4 Jiangsu Hengrui Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Jiangsu Hengrui Recent Developments/Updates
7.6.6 Jiangsu Hengrui Competitive Strengths & Weaknesses
7.7 Gan&Lee
7.7.1 Gan&Lee Details
7.7.2 Gan&Lee Major Business
7.7.3 Gan&Lee Biosimilar Product and Services
7.7.4 Gan&Lee Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Gan&Lee Recent Developments/Updates
7.7.6 Gan&Lee Competitive Strengths & Weaknesses
7.8 Tonghua Dongbao
7.8.1 Tonghua Dongbao Details
7.8.2 Tonghua Dongbao Major Business
7.8.3 Tonghua Dongbao Biosimilar Product and Services
7.8.4 Tonghua Dongbao Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Tonghua Dongbao Recent Developments/Updates
7.8.6 Tonghua Dongbao Competitive Strengths & Weaknesses
7.9 United Laboratory
7.9.1 United Laboratory Details
7.9.2 United Laboratory Major Business
7.9.3 United Laboratory Biosimilar Product and Services
7.9.4 United Laboratory Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 United Laboratory Recent Developments/Updates
7.9.6 United Laboratory Competitive Strengths & Weaknesses
7.10 3SBIO
7.10.1 3SBIO Details
7.10.2 3SBIO Major Business
7.10.3 3SBIO Biosimilar Product and Services
7.10.4 3SBIO Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 3SBIO Recent Developments/Updates
7.10.6 3SBIO Competitive Strengths & Weaknesses
7.11 Luye Pharma
7.11.1 Luye Pharma Details
7.11.2 Luye Pharma Major Business
7.11.3 Luye Pharma Biosimilar Product and Services
7.11.4 Luye Pharma Biosimilar Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Luye Pharma Recent Developments/Updates
7.11.6 Luye Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biosimilar Industry Chain
8.2 Biosimilar Upstream Analysis
8.3 Biosimilar Midstream Analysis
8.4 Biosimilar Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF FIGURES
Table 1. World Biosimilar Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Biosimilar Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Biosimilar Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Biosimilar Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Biosimilar Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biosimilar Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Biosimilar Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Biosimilar Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Biosimilar Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Biosimilar Players in 2025
Table 12. World Biosimilar Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Biosimilar Company Evaluation Quadrant
Table 14. Head Office of Key Biosimilar Players
Table 15. Biosimilar Market: Company Product Type Footprint
Table 16. Biosimilar Market: Company Product Application Footprint
Table 17. Biosimilar Mergers & Acquisitions Activity
Table 18. United States VS China Biosimilar Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Biosimilar Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Biosimilar Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biosimilar Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Biosimilar Revenue Market Share (2021-2026)
Table 23. China Based Biosimilar Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biosimilar Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Biosimilar Revenue Market Share (2021-2026)
Table 26. Rest of World Based Biosimilar Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Biosimilar Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Biosimilar Revenue Market Share (2021-2026)
Table 29. World Biosimilar Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Biosimilar Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Biosimilar Market Size by Type (2027-2032) & (USD Million)
Table 32. World Biosimilar Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Biosimilar Market Size by Application (2021-2026) & (USD Million)
Table 34. World Biosimilar Market Size by Application (2027-2032) & (USD Million)
Table 35. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Qilu Pharmaceutical Major Business
Table 37. Qilu Pharmaceutical Biosimilar Product and Services
Table 38. Qilu Pharmaceutical Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Qilu Pharmaceutical Recent Developments/Updates
Table 40. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 41. Bio-Thera Basic Information, Manufacturing Base and Competitors
Table 42. Bio-Thera Major Business
Table 43. Bio-Thera Biosimilar Product and Services
Table 44. Bio-Thera Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Bio-Thera Recent Developments/Updates
Table 46. Bio-Thera Competitive Strengths & Weaknesses
Table 47. Zhejiang Hisun Basic Information, Manufacturing Base and Competitors
Table 48. Zhejiang Hisun Major Business
Table 49. Zhejiang Hisun Biosimilar Product and Services
Table 50. Zhejiang Hisun Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Zhejiang Hisun Recent Developments/Updates
Table 52. Zhejiang Hisun Competitive Strengths & Weaknesses
Table 53. Shanghai Henlius Basic Information, Manufacturing Base and Competitors
Table 54. Shanghai Henlius Major Business
Table 55. Shanghai Henlius Biosimilar Product and Services
Table 56. Shanghai Henlius Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Shanghai Henlius Recent Developments/Updates
Table 58. Shanghai Henlius Competitive Strengths & Weaknesses
Table 59. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 60. Innovent Biologics Major Business
Table 61. Innovent Biologics Biosimilar Product and Services
Table 62. Innovent Biologics Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Innovent Biologics Recent Developments/Updates
Table 64. Innovent Biologics Competitive Strengths & Weaknesses
Table 65. Jiangsu Hengrui Basic Information, Manufacturing Base and Competitors
Table 66. Jiangsu Hengrui Major Business
Table 67. Jiangsu Hengrui Biosimilar Product and Services
Table 68. Jiangsu Hengrui Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Jiangsu Hengrui Recent Developments/Updates
Table 70. Jiangsu Hengrui Competitive Strengths & Weaknesses
Table 71. Gan&Lee Basic Information, Manufacturing Base and Competitors
Table 72. Gan&Lee Major Business
Table 73. Gan&Lee Biosimilar Product and Services
Table 74. Gan&Lee Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Gan&Lee Recent Developments/Updates
Table 76. Gan&Lee Competitive Strengths & Weaknesses
Table 77. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
Table 78. Tonghua Dongbao Major Business
Table 79. Tonghua Dongbao Biosimilar Product and Services
Table 80. Tonghua Dongbao Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Tonghua Dongbao Recent Developments/Updates
Table 82. Tonghua Dongbao Competitive Strengths & Weaknesses
Table 83. United Laboratory Basic Information, Manufacturing Base and Competitors
Table 84. United Laboratory Major Business
Table 85. United Laboratory Biosimilar Product and Services
Table 86. United Laboratory Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. United Laboratory Recent Developments/Updates
Table 88. United Laboratory Competitive Strengths & Weaknesses
Table 89. 3SBIO Basic Information, Manufacturing Base and Competitors
Table 90. 3SBIO Major Business
Table 91. 3SBIO Biosimilar Product and Services
Table 92. 3SBIO Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. 3SBIO Recent Developments/Updates
Table 94. 3SBIO Competitive Strengths & Weaknesses
Table 95. Luye Pharma Basic Information, Manufacturing Base and Competitors
Table 96. Luye Pharma Major Business
Table 97. Luye Pharma Biosimilar Product and Services
Table 98. Luye Pharma Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Luye Pharma Recent Developments/Updates
Table 100. Luye Pharma Competitive Strengths & Weaknesses
Table 101. Global Key Players of Biosimilar Upstream (Raw Materials)
Table 102. Global Biosimilar Typical Customers
LIST OF FIGURES
Figure 1. Biosimilar Picture
Figure 2. World Biosimilar Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Biosimilar Total Revenue (2021-2032) & (USD Million)
Figure 4. World Biosimilar Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Biosimilar Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Biosimilar Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Biosimilar Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Biosimilar Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Biosimilar Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Biosimilar Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Biosimilar Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Biosimilar Revenue (2021-2032) & (USD Million)
Figure 13. Biosimilar Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biosimilar Consumption Value (2021-2032) & (USD Million)
Figure 16. World Biosimilar Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Biosimilar Consumption Value (2021-2032) & (USD Million)
Figure 18. China Biosimilar Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Biosimilar Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Biosimilar Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Biosimilar Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Biosimilar Consumption Value (2021-2032) & (USD Million)
Figure 23. India Biosimilar Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Biosimilar by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biosimilar Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biosimilar Markets in 2025
Figure 27. United States VS China: Biosimilar Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Biosimilar Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Biosimilar Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Biosimilar Market Size Market Share by Type in 2025
Figure 31. Biosimilar Monoclonal Antibodies
Figure 32. Biosimilar Insulin
Figure 33. Others
Figure 34. World Biosimilar Market Size Market Share by Type (2021-2032)
Figure 35. World Biosimilar Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 36. World Biosimilar Market Size Market Share by Application in 2025
Figure 37. Cancer
Figure 38. Immunological Diseases
Figure 39. Diabetes
Figure 40. Others
Figure 41. World Biosimilar Market Size Market Share by Application (2021-2032)
Figure 42. Biosimilar Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Table 1. World Biosimilar Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Biosimilar Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Biosimilar Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Biosimilar Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Biosimilar Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biosimilar Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Biosimilar Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Biosimilar Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Biosimilar Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Biosimilar Players in 2025
Table 12. World Biosimilar Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Biosimilar Company Evaluation Quadrant
Table 14. Head Office of Key Biosimilar Players
Table 15. Biosimilar Market: Company Product Type Footprint
Table 16. Biosimilar Market: Company Product Application Footprint
Table 17. Biosimilar Mergers & Acquisitions Activity
Table 18. United States VS China Biosimilar Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Biosimilar Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Biosimilar Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biosimilar Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Biosimilar Revenue Market Share (2021-2026)
Table 23. China Based Biosimilar Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biosimilar Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Biosimilar Revenue Market Share (2021-2026)
Table 26. Rest of World Based Biosimilar Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Biosimilar Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Biosimilar Revenue Market Share (2021-2026)
Table 29. World Biosimilar Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Biosimilar Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Biosimilar Market Size by Type (2027-2032) & (USD Million)
Table 32. World Biosimilar Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Biosimilar Market Size by Application (2021-2026) & (USD Million)
Table 34. World Biosimilar Market Size by Application (2027-2032) & (USD Million)
Table 35. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Qilu Pharmaceutical Major Business
Table 37. Qilu Pharmaceutical Biosimilar Product and Services
Table 38. Qilu Pharmaceutical Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Qilu Pharmaceutical Recent Developments/Updates
Table 40. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 41. Bio-Thera Basic Information, Manufacturing Base and Competitors
Table 42. Bio-Thera Major Business
Table 43. Bio-Thera Biosimilar Product and Services
Table 44. Bio-Thera Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Bio-Thera Recent Developments/Updates
Table 46. Bio-Thera Competitive Strengths & Weaknesses
Table 47. Zhejiang Hisun Basic Information, Manufacturing Base and Competitors
Table 48. Zhejiang Hisun Major Business
Table 49. Zhejiang Hisun Biosimilar Product and Services
Table 50. Zhejiang Hisun Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Zhejiang Hisun Recent Developments/Updates
Table 52. Zhejiang Hisun Competitive Strengths & Weaknesses
Table 53. Shanghai Henlius Basic Information, Manufacturing Base and Competitors
Table 54. Shanghai Henlius Major Business
Table 55. Shanghai Henlius Biosimilar Product and Services
Table 56. Shanghai Henlius Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Shanghai Henlius Recent Developments/Updates
Table 58. Shanghai Henlius Competitive Strengths & Weaknesses
Table 59. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 60. Innovent Biologics Major Business
Table 61. Innovent Biologics Biosimilar Product and Services
Table 62. Innovent Biologics Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Innovent Biologics Recent Developments/Updates
Table 64. Innovent Biologics Competitive Strengths & Weaknesses
Table 65. Jiangsu Hengrui Basic Information, Manufacturing Base and Competitors
Table 66. Jiangsu Hengrui Major Business
Table 67. Jiangsu Hengrui Biosimilar Product and Services
Table 68. Jiangsu Hengrui Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Jiangsu Hengrui Recent Developments/Updates
Table 70. Jiangsu Hengrui Competitive Strengths & Weaknesses
Table 71. Gan&Lee Basic Information, Manufacturing Base and Competitors
Table 72. Gan&Lee Major Business
Table 73. Gan&Lee Biosimilar Product and Services
Table 74. Gan&Lee Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Gan&Lee Recent Developments/Updates
Table 76. Gan&Lee Competitive Strengths & Weaknesses
Table 77. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
Table 78. Tonghua Dongbao Major Business
Table 79. Tonghua Dongbao Biosimilar Product and Services
Table 80. Tonghua Dongbao Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Tonghua Dongbao Recent Developments/Updates
Table 82. Tonghua Dongbao Competitive Strengths & Weaknesses
Table 83. United Laboratory Basic Information, Manufacturing Base and Competitors
Table 84. United Laboratory Major Business
Table 85. United Laboratory Biosimilar Product and Services
Table 86. United Laboratory Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. United Laboratory Recent Developments/Updates
Table 88. United Laboratory Competitive Strengths & Weaknesses
Table 89. 3SBIO Basic Information, Manufacturing Base and Competitors
Table 90. 3SBIO Major Business
Table 91. 3SBIO Biosimilar Product and Services
Table 92. 3SBIO Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. 3SBIO Recent Developments/Updates
Table 94. 3SBIO Competitive Strengths & Weaknesses
Table 95. Luye Pharma Basic Information, Manufacturing Base and Competitors
Table 96. Luye Pharma Major Business
Table 97. Luye Pharma Biosimilar Product and Services
Table 98. Luye Pharma Biosimilar Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Luye Pharma Recent Developments/Updates
Table 100. Luye Pharma Competitive Strengths & Weaknesses
Table 101. Global Key Players of Biosimilar Upstream (Raw Materials)
Table 102. Global Biosimilar Typical Customers
LIST OF FIGURES
Figure 1. Biosimilar Picture
Figure 2. World Biosimilar Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Biosimilar Total Revenue (2021-2032) & (USD Million)
Figure 4. World Biosimilar Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Biosimilar Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Biosimilar Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Biosimilar Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Biosimilar Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Biosimilar Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Biosimilar Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Biosimilar Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Biosimilar Revenue (2021-2032) & (USD Million)
Figure 13. Biosimilar Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biosimilar Consumption Value (2021-2032) & (USD Million)
Figure 16. World Biosimilar Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Biosimilar Consumption Value (2021-2032) & (USD Million)
Figure 18. China Biosimilar Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Biosimilar Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Biosimilar Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Biosimilar Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Biosimilar Consumption Value (2021-2032) & (USD Million)
Figure 23. India Biosimilar Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Biosimilar by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biosimilar Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biosimilar Markets in 2025
Figure 27. United States VS China: Biosimilar Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Biosimilar Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Biosimilar Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Biosimilar Market Size Market Share by Type in 2025
Figure 31. Biosimilar Monoclonal Antibodies
Figure 32. Biosimilar Insulin
Figure 33. Others
Figure 34. World Biosimilar Market Size Market Share by Type (2021-2032)
Figure 35. World Biosimilar Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 36. World Biosimilar Market Size Market Share by Application in 2025
Figure 37. Cancer
Figure 38. Immunological Diseases
Figure 39. Diabetes
Figure 40. Others
Figure 41. World Biosimilar Market Size Market Share by Application (2021-2032)
Figure 42. Biosimilar Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
More Publications
Global Biologics and Biosimilars Market 2025 by Company, Regions, Type and Application, Forecast to 2031
US$ 3,480.00
June 2025
140 pages
Global Interferon Alpha-2a Biosimilar Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
January 2026
99 pages
Global Biosimilar Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
January 2026
100 pages
Global Biosimilar Monoclonal Antibodies Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
June 2026
118 pages
